Literature DB >> 23914022

Diabetes and cardiovascular disease: what have we learned in 2012?

Glenn R Cunningham1.   

Abstract

Entities:  

Keywords:  Body mass index; United States/epidemiology; diabetes mellitus, type 2/epidemiology/ethnology/prevention & control; ethnic groups/statistics & numerical data; hypoglycemic agents/therapeutic use; longitudinal studies

Mesh：

Substances：

Year:  2013        PMID： 23914022      PMCID： PMC3709222     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  9 in total

Review 1.  Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications.

Authors:  Richard M Bergenstal; Clifford J Bailey; David M Kendall
Journal:  Am J Med       Date:  2010-04       Impact factor: 4.965

2.  Basal insulin and cardiovascular and other outcomes in dysglycemia.

Authors:  Hertzel C Gerstein; Jackie Bosch; Gilles R Dagenais; Rafael Díaz; Hyejung Jung; Aldo P Maggioni; Janice Pogue; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
Journal:  N Engl J Med       Date:  2012-06-11       Impact factor: 91.245

3.  Ethnic disparities in diabetic complications in an insured population.

Authors:  Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

4.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

5.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

6.  Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults.

Authors:  Peter T Campbell; Christina C Newton; Alpa V Patel; Eric J Jacobs; Susan M Gapstur
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

7.  Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.

Authors:  Ricardo V Cohen; Jose C Pinheiro; Carlos A Schiavon; João E Salles; Bernardo L Wajchenberg; David E Cummings
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

8.  Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.

Authors:  David Russell-Jones; Robert M Cuddihy; Markolf Hanefeld; Ajay Kumar; Jose G González; Melanie Chan; Anne M Wolka; Marilyn K Boardman
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

Review 9.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.